hcp-engagement
(5)
Bozidar Jovicevic
Bozidar Jovicevic is the CEO and co-founder of Evermed, a New York startup that lets medical societies and healthcare organizations launch a Netflix-style, on-demand video library in about 90 days. A medical doctor and FIDE chess master who spent 17 years running global digital initiatives at Novartis and Sanofi, he now builds technology that turns conference recordings and expert lectures into searchable, monetizable continuing-education libraries for physicians. He also hosts the Pharma Launch Secrets and Digital Innovators Circle podcasts.
Dan Cornwell
Dan Cornwell is the founder and CEO of PrescriberPoint, a Boston-based, AI-enabled medication access platform that helps clinicians cut through the paperwork between writing a prescription and a patient actually getting their medicine. Spun out of Eli Lilly in partnership with BCG Digital Ventures, the company raised seed backing from an unusual coalition of would-be rivals - Lilly, Pfizer, Adobe and Mastercard. Before PrescriberPoint, Cornwell ran the nurse-staffing marketplace IntelyCare and advised companies on building disruptive businesses at BCG Digital Ventures. A Yale historian turned Wharton-trained operator, he keeps returning to the same problem: the messy gap between a good intention and a completed transaction.
Eric Bolesh
Eric Bolesh is the Chief Executive Officer of Cutting Edge Information, a Research Triangle Park firm that has become the de facto industry standard for fair market value (FMV) data in life sciences. One of the company's first employees back in 2002, he spent two decades turning the murky question of what a cardiologist in Bulgaria or a pharmacist in the UK should be paid into a defensible, data-driven discipline. A Harvard graduate and frequent speaker at compliance conferences, he is widely regarded as a thought leader on healthcare-provider engagement and the economics of compliant compensation across more than 130 global markets.
John Vitalie
John Vitalie is the CEO of Aktana, a San Francisco-based AI platform company that helps global life sciences organizations optimize commercial engagement with healthcare providers. A three-time software CEO with leadership stints at Salesforce, Oracle, and Siebel Systems, Vitalie brings a decade of pioneering AI in life sciences to a company building what it calls a Contextual Intelligence Engine - blending AI, human insight, and omnichannel orchestration to make every pharma sales interaction more timely and personalized. Recognized as one of the Top 25 Biotech CEOs of 2022 by the Healthcare Technology Report, he champions a philosophy that AI should augment human judgment, not replace it.
Supreet Deshpande
Supreet Deshpande is Co-Founder and CEO of Synthio Labs, a Y Combinator-backed startup building clinical-grade voice AI for the life sciences industry. Drawing on his experience leading Gen AI for Life Sciences at McKinsey and analytics work at ZS Associates and JPMorgan Chase, Deshpande is solving a stubborn pharma problem: 70% of physicians never hear from a field team despite billions spent. Synthio's AI voice agents - reaching every clinician and patient with compliant, multilingual, FDA-aligned conversations - raised a $5M seed round led by Elevation Capital in November 2025 and already counts several Top 10 pharma companies as customers.